PlainPharmaWatch

CMS Open Payments · Tool

CSL Plasma Inc. vs Spinecraft, LLC

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

Spinecraft, LLC has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 2,668, versus 100 for the other company. Its single largest recorded recipient represents 32.6% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

CSL Plasma Inc.
HHI 100 · top recipient 4.5%
Ranked #1,690 of 1,838 companies by HHI
Spinecraft, LLC
HHI 2,668 · top recipient 32.6%
Ranked #619 of 1,838 companies by HHI

Payment Overview

Company A

CSL Plasma Inc.

Total Payments
$17.9M
% of Industry
0.1%
Transactions
12,905
Avg per Transaction
$1.4K
Recipients
12,905
Avg per Recipient
$1.4K
Payment Types
1
Top Payment Type
Consulting Fee
Company B

Spinecraft, LLC

Total Payments
$18.2M
% of Industry
0.1%
Transactions
32
Avg per Transaction
$567.7K
Recipients
27
Avg per Recipient
$672.9K
Payment Types
1
Top Payment Type
Royalty or License

Highlighted values indicate the higher figure for each metric.

Total payments compared

CSL Plasma Inc. vs Spinecraft, LLC - total reported payments in CMS Open Payments PY2024

Spinecraft, LLC$18.2MCSL Plasma Inc.$17.9M

General Payment Types Breakdown

Category shares use each company's General Payments total, not the all-tracks (General + Research + Ownership) hero figure.

CSL Plasma Inc.

Consulting Fee $17.9M

100.0%

Spinecraft, LLC

Royalty or License $201.8K

100.0%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

CSL Plasma Inc.

  1. 1

    MAJED REFAAI

    $807,450.00 · 125 txns

  2. 2

    JENNIFER PARSLEY

    $415,425.00 · 76 txns

  3. 3

    CHRISTINA SAMATHANAM

    $400,657.32 · 190 txns

  4. 4

    MICHAEL GIBSON

    $388,260.72 · 274 txns

  5. 5

    JOHN MCKINNEY

    $356,327.50 · 133 txns

Spinecraft, LLC

  1. 1

    Anis Mekhail Mr

    $65,747.25 · 6 txns

  2. 2

    Steven Mather Mr

    $58,514.44 · 6 txns

  3. 3

    Steven Mardjetko Mr

    $51,155.65 · 6 txns

  4. 4

    Kamal Ibrahim Mr

    $21,962.62 · 6 txns

  5. 5

    Khaled Kebaish Mr

    $4,434.17 · 3 txns

Summary Comparison

Metric CSL Plasma Inc. Spinecraft, LLC
Total Payments $17.9M $18.2M
% of Industry Total 0.1% 0.1%
Transaction Count 12,905 32
Avg per Transaction $1.4K $567.7K
Recipient Count 12,905 27
Avg per Recipient $1.4K $672.9K
Payment Type Count 1 1
Top Payment Type Consulting Fee Royalty or License

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.